Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Flecainide acetate 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Flecainide acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely flecainide acetate 100 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Flecainide acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Flecainide acetate 150mg/15mL injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Flecainide acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely flecainide acetate 150 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Flecainide acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Flecainide acetate 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Flecainide acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Flecainide acetate 50 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Flecainide acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely flecainide acetate 100 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Flecainide acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely flecainide acetate 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Flecainide acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely flecainide acetate 150 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Flecainide acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely flecainide acetate 150 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Flecainide acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Flecainide acetate 50 mg oral tablet |
Has precise active ingredient |
True |
Flecainide acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely flecainide acetate 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Flecainide acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely flecainide acetate 150 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Flecainide acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely flecainide acetate 150 milligram/15 milliliter conventional release solution for injection ampule |
Has basis of strength substance (attribute) |
False |
Flecainide acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely flecainide acetate 150 milligram/15 milliliter conventional release solution for injection ampule |
Has precise active ingredient |
False |
Flecainide acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely flecainide acetate 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Flecainide acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely flecainide acetate 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Flecainide acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |